Archives

by in
Entry Author Date Location
Fighting a Global War on Rare Diseases 03/20/13 New York
East Coast Life Sciences Roundup: Zafgen, Moderna, Merck, More 12/07/12 Boston
In Wake of Alzheimer’s Disaster, Wall Street Revisits Pfizer and J&J 08/08/12 New York
iPierian Zeroes In on Antibodies for Alzheimer’s, Neurodegeneration 05/21/12 San Francisco
The Greater Seattle Brain Science Cluster 03/16/12 Seattle
Concert, Alere, TremRx, & More Names from Boston Life Sciences News 03/02/12 Boston
Charles River, FirstFuel, Quiet Logistics, & More Boston Deal News 02/29/12 Boston
Intellect Embraces Wide-Ranging Approach to Fighting Brain Diseases 02/14/12 New York
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Medivation Fails Alzheimer’s Trial, Pfizer Drops Out of Partnership 01/17/12 San Francisco
Merck Chemists Use High-Tech Science to Combat Alzheimer’s Disease Challenge 12/14/11 New York
Eli Lilly CEO John Lechleiter on Tackling the Pharmaceutical R&D Crisis (Part 1) 11/21/11 National
UW Spinoff Impel NeuroPharma Nabs Two Big Pharma Deals, $500K in Angel Financing 10/20/11 Seattle
Xconomist of the Week: Pfizer’s Barbara Dalton to Speak at Our NY Life Sciences 2031 Forum 09/29/11 New York
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News 07/29/11 Boston
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s 07/25/11 Boston
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs 05/25/11 Boston
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma 05/24/11 San Francisco
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives 05/13/11 San Francisco
Hitting the Target, Missing the Mark: How Targeted Therapies Have Left Patients Wanting 04/14/11 Seattle
Medivation, Pfizer Fail Huntington’s Test 04/11/11 San Francisco
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders 03/01/11 Boston
J&J Subsidiary Backs Alzheimer Drug Discovery at Sanford-Burnham, Portable Genomics to Move to San Diego, Ardea Plans Secondary Stock Offering, & More San Diego Life Sciences News 01/20/11 San Diego
Sanford-Burnham Strikes Deal With J&J, Second Big Pharma Alliance in a Month 01/17/11 San Diego
Neuroptix Raises $4.6M 01/07/11 Boston
Allon Starts Trial for Brain Disease 01/06/11 Seattle
$7M for Satori Pharmaceuticals 01/04/11 Boston
Biogen Idec Buys Drug Rights from Neurimmune for $32.5M 12/21/10 Boston
Fighting Alzheimer’s: New Hope in a New Year Through Innovation 12/20/10 Seattle
Uncle Sam Delivers $18.4M in Research Awards to Michigan Biotechs 11/05/10 Detroit
Page 2 of 4 « previous page · next page »